Krystal Biotech, Inc. ( KRYS) - Key Metrics
KRYS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.70 | $1.78 | $2.68 | $2.60 |
| 2025Q3 | $3.38 | $2.74 | $1.37 | $1.31 |
| 2025Q2 | $3.32 | $1.33 | $1.82 | $1.76 |
| 2025Q1 | $3.06 | $1.24 | $1.07 | $0.86 |
KRYS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 34.71 |
| 2025Q3 | ? | 16.10 |
| 2025Q2 | ? | 25.92 |
| 2025Q1 | ? | 36.35 |
KRYS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.97% | ? |
| 2025Q4 | 1.06% | ? |
| 2025Q3 | 0.74% | ? |
| 2025Q2 | 1.28% | ? |
| 2025Q1 | 0.48% | ? |
KRYS
Price: $323.43
52 week price:
Earnings Per Share: 7.46 USD
P/E Ratio: 40.98
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 151900
Ebitda: -2.1 millionMarket Capitalization: 8.9 billion